Report Detail

Pharma & Healthcare Global Sulphonamides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4592262
  • |
  • 05 June, 2024
  • |
  • Global
  • |
  • 116 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Sulphonamides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Sulphonamides industry chain, the market status of Skin Infections (Orally Absorbable Sulfonamide, Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)), Gastro Intestinal Tract (GIT) Infection (Orally Absorbable Sulfonamide, Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sulphonamides.
Regionally, the report analyzes the Sulphonamides markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sulphonamides market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sulphonamides market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sulphonamides industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Orally Absorbable Sulfonamide, Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sulphonamides market.
Regional Analysis: The report involves examining the Sulphonamides market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sulphonamides market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sulphonamides:
Company Analysis: Report covers individual Sulphonamides manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sulphonamides This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Skin Infections, Gastro Intestinal Tract (GIT) Infection).
Technology Analysis: Report covers specific technologies relevant to Sulphonamides. It assesses the current state, advancements, and potential future developments in Sulphonamides areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sulphonamides market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sulphonamides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Market segment by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Major players covered
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sulphonamides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sulphonamides, with price, sales, revenue and global market share of Sulphonamides from 2019 to 2024.
Chapter 3, the Sulphonamides competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sulphonamides breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Sulphonamides market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sulphonamides.
Chapter 14 and 15, to describe Sulphonamides sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Sulphonamides
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sulphonamides Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Orally Absorbable Sulfonamide
    • 1.3.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
    • 1.3.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sulphonamides Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Skin Infections
    • 1.4.3 Gastro Intestinal Tract (GIT) Infection
    • 1.4.4 Meningitis
  • 1.5 Global Sulphonamides Market Size & Forecast
    • 1.5.1 Global Sulphonamides Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Sulphonamides Sales Quantity (2019-2030)
    • 1.5.3 Global Sulphonamides Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Sulphonamides Product and Services
    • 2.1.4 Abbott Laboratories Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 Boehringer Ingelheim Pharmaceuticals
    • 2.2.1 Boehringer Ingelheim Pharmaceuticals Details
    • 2.2.2 Boehringer Ingelheim Pharmaceuticals Major Business
    • 2.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product and Services
    • 2.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
  • 2.3 Bayer AG
    • 2.3.1 Bayer AG Details
    • 2.3.2 Bayer AG Major Business
    • 2.3.3 Bayer AG Sulphonamides Product and Services
    • 2.3.4 Bayer AG Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bayer AG Recent Developments/Updates
  • 2.4 GlaxoSmithKline
    • 2.4.1 GlaxoSmithKline Details
    • 2.4.2 GlaxoSmithKline Major Business
    • 2.4.3 GlaxoSmithKline Sulphonamides Product and Services
    • 2.4.4 GlaxoSmithKline Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GlaxoSmithKline Recent Developments/Updates
  • 2.5 King Pharmaceuticals
    • 2.5.1 King Pharmaceuticals Details
    • 2.5.2 King Pharmaceuticals Major Business
    • 2.5.3 King Pharmaceuticals Sulphonamides Product and Services
    • 2.5.4 King Pharmaceuticals Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 King Pharmaceuticals Recent Developments/Updates
  • 2.6 Mylan Pharmaceuticals
    • 2.6.1 Mylan Pharmaceuticals Details
    • 2.6.2 Mylan Pharmaceuticals Major Business
    • 2.6.3 Mylan Pharmaceuticals Sulphonamides Product and Services
    • 2.6.4 Mylan Pharmaceuticals Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Mylan Pharmaceuticals Recent Developments/Updates
  • 2.7 Novartis International AG
    • 2.7.1 Novartis International AG Details
    • 2.7.2 Novartis International AG Major Business
    • 2.7.3 Novartis International AG Sulphonamides Product and Services
    • 2.7.4 Novartis International AG Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Novartis International AG Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Sulphonamides Product and Services
    • 2.8.4 Pfizer Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 Par Pharmaceutical
    • 2.9.1 Par Pharmaceutical Details
    • 2.9.2 Par Pharmaceutical Major Business
    • 2.9.3 Par Pharmaceutical Sulphonamides Product and Services
    • 2.9.4 Par Pharmaceutical Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Par Pharmaceutical Recent Developments/Updates
  • 2.10 Roche Holding AG
    • 2.10.1 Roche Holding AG Details
    • 2.10.2 Roche Holding AG Major Business
    • 2.10.3 Roche Holding AG Sulphonamides Product and Services
    • 2.10.4 Roche Holding AG Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Roche Holding AG Recent Developments/Updates
  • 2.11 Sanofi Aventis
    • 2.11.1 Sanofi Aventis Details
    • 2.11.2 Sanofi Aventis Major Business
    • 2.11.3 Sanofi Aventis Sulphonamides Product and Services
    • 2.11.4 Sanofi Aventis Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Sanofi Aventis Recent Developments/Updates
  • 2.12 Stiefel Laboratories
    • 2.12.1 Stiefel Laboratories Details
    • 2.12.2 Stiefel Laboratories Major Business
    • 2.12.3 Stiefel Laboratories Sulphonamides Product and Services
    • 2.12.4 Stiefel Laboratories Sulphonamides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Stiefel Laboratories Recent Developments/Updates

3 Competitive Environment: Sulphonamides by Manufacturer

  • 3.1 Global Sulphonamides Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Sulphonamides Revenue by Manufacturer (2019-2024)
  • 3.3 Global Sulphonamides Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Sulphonamides by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Sulphonamides Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Sulphonamides Manufacturer Market Share in 2023
  • 3.5 Sulphonamides Market: Overall Company Footprint Analysis
    • 3.5.1 Sulphonamides Market: Region Footprint
    • 3.5.2 Sulphonamides Market: Company Product Type Footprint
    • 3.5.3 Sulphonamides Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sulphonamides Market Size by Region
    • 4.1.1 Global Sulphonamides Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Sulphonamides Consumption Value by Region (2019-2030)
    • 4.1.3 Global Sulphonamides Average Price by Region (2019-2030)
  • 4.2 North America Sulphonamides Consumption Value (2019-2030)
  • 4.3 Europe Sulphonamides Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Sulphonamides Consumption Value (2019-2030)
  • 4.5 South America Sulphonamides Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Sulphonamides Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Sulphonamides Sales Quantity by Type (2019-2030)
  • 5.2 Global Sulphonamides Consumption Value by Type (2019-2030)
  • 5.3 Global Sulphonamides Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Sulphonamides Sales Quantity by Application (2019-2030)
  • 6.2 Global Sulphonamides Consumption Value by Application (2019-2030)
  • 6.3 Global Sulphonamides Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Sulphonamides Sales Quantity by Type (2019-2030)
  • 7.2 North America Sulphonamides Sales Quantity by Application (2019-2030)
  • 7.3 North America Sulphonamides Market Size by Country
    • 7.3.1 North America Sulphonamides Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Sulphonamides Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Sulphonamides Sales Quantity by Type (2019-2030)
  • 8.2 Europe Sulphonamides Sales Quantity by Application (2019-2030)
  • 8.3 Europe Sulphonamides Market Size by Country
    • 8.3.1 Europe Sulphonamides Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Sulphonamides Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sulphonamides Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Sulphonamides Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Sulphonamides Market Size by Region
    • 9.3.1 Asia-Pacific Sulphonamides Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Sulphonamides Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Sulphonamides Sales Quantity by Type (2019-2030)
  • 10.2 South America Sulphonamides Sales Quantity by Application (2019-2030)
  • 10.3 South America Sulphonamides Market Size by Country
    • 10.3.1 South America Sulphonamides Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Sulphonamides Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sulphonamides Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Sulphonamides Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Sulphonamides Market Size by Country
    • 11.3.1 Middle East & Africa Sulphonamides Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Sulphonamides Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Sulphonamides Market Drivers
  • 12.2 Sulphonamides Market Restraints
  • 12.3 Sulphonamides Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sulphonamides and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sulphonamides
  • 13.3 Sulphonamides Production Process
  • 13.4 Sulphonamides Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sulphonamides Typical Distributors
  • 14.3 Sulphonamides Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sulphonamides. Industry analysis & Market Report on Sulphonamides is a syndicated market report, published as Global Sulphonamides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Sulphonamides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,756.16
    4,134.24
    5,512.32
    3,253.80
    4,880.70
    6,507.60
    556,243.20
    834,364.80
    1,112,486.40
    290,962.80
    436,444.20
    581,925.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report